On Monday, June 26, 2017, the Biden Foundation announced the launch of the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.
Senate Majority Leader Mitch McConnell (R-Kentucky) faces the challenge of bridging the gap between conservatives who want a full Obamacare repeal and Republican members facing protests at home over losing Medicaid expansion.
As part of its new Drug Competition Action Plan, the FDA has announced it will seek to spur innovation by allowing for accelerated approvals of generic drugs without competitors. It also published a list of drugs without approved generics that could be eligible for this expedited review process.
A newly published analysis, supported by an editorial, finds that the growing prevalence of cosmetic-related adverse events may warrant stronger regulation of these products used to alter appearance.
While treatments prescribed for people with chronic pulmonary disease (COPD) and asthma–COPD overlap syndrome (ACOS) are similar, there is a need for a clearer therapeutic approach for patients with ACOS, according to a new study.
Data from multiple studies have demonstrated the efficacy of Venclexta/Venclyxto in treating relapsed or refractory chronic lymphocytic leukemia, according to Roche.
Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Grenada Health.
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST